跳至主要内容
临床试验/JPRN-UMIN000004133
JPRN-UMIN000004133已完成未知

A Clinical study to which Anti-emetic effect of change of 5-HT3RA is evaluated by using MAT in MEC for gastrointestinal cancer. - A Clinical study to which Anti-emetic effect of change of 5-HT3RA is evaluated by using MAT in MEC for gastrointestinal cancer.

Kochi Health Sciences Center0 个研究点目标入组 40 人开始时间: 2010年9月2日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
入组人数
40

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1) The change (The change of Dose is included) in the chemotherapeutic regimen is scheduled before and after the change of 5- HT3RA. 2) Hypersensitivity or severe drug allergy for Aloxi or other 5-HT3RA. 3) Hypersensitivity or severe drug allergy for dexamethasone. 4) Any other patient whom the physician in charge of the study judges to be not eligible

研究者

相似试验